These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34510113)

  • 41. HMGA2-WIF1 Rearrangements Characterize a Distinctive Subset of Salivary Pleomorphic Adenomas With Prominent Trabecular (Canalicular Adenoma-like) Morphology.
    Agaimy A; Ihrler S; Baněčková M; Costés Martineau V; Mantsopoulos K; Hartmann A; Iro H; Stoehr R; Skálová A
    Am J Surg Pathol; 2022 Feb; 46(2):190-199. PubMed ID: 34324456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.
    Amato E; Molin MD; Mafficini A; Yu J; Malleo G; Rusev B; Fassan M; Antonello D; Sadakari Y; Castelli P; Zamboni G; Maitra A; Salvia R; Hruban RH; Bassi C; Capelli P; Lawlor RT; Goggins M; Scarpa A
    J Pathol; 2014 Jul; 233(3):217-27. PubMed ID: 24604757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.
    Agaimy A; Baněčková M; Ihrler S; Mueller SK; Franchi A; Hartmann A; Stoehr R; Skálová A
    Am J Surg Pathol; 2021 Sep; 45(9):1166-1178. PubMed ID: 33871952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
    Skálová A; Hyrcza MD; Leivo I
    Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP; Weston JD; Yu B; Selinger CI; Ekmejian R; Eviston TJ; Lum T; Gao K; Boyer M; O'Toole SA; Clark JR; Gupta R
    Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern.
    Delgado R; Klimstra D; Albores-Saavedra J
    Cancer; 1996 Sep; 78(5):958-67. PubMed ID: 8780532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway.
    Volckmar AL; Leichsenring J; Flechtenmacher C; Pfarr N; Siebolts U; Kirchner M; Budczies J; Bockmayr M; Ridinger K; Lorenz K; Herpel E; Noske A; Weichert W; Klauschen F; Schirmacher P; Penzel R; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2017 Jan; 56(1):11-17. PubMed ID: 27438523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathological profile of sclerosing polycystic adenoma/adenosis: A systematic review.
    de Carvalho Kimura T; de Lima-Souza RA; Scarini JF; Lavareze L; Egal ESA; Altemani A; Mariano FV
    Head Neck; 2023 Sep; 45(9):2449-2457. PubMed ID: 37403748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sclerosing polycystic adenosis of the parotid gland: report of one case diagnosed by fine-needle cytology with in situ malignant transformation.
    Fulciniti F; Losito NS; Ionna F; Longo F; Aversa C; Botti G; Foschini MP
    Diagn Cytopathol; 2010 May; 38(5):368-73. PubMed ID: 19937766
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Bahmad HF; Elhammady G; Gass JM; Paramo JC; Poppiti R; Alexis J
    Curr Issues Mol Biol; 2023 Jan; 45(2):954-962. PubMed ID: 36826006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
    Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
    APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm.
    Nakaguro M; Urano M; Ogawa I; Hirai H; Yamamoto Y; Yamaguchi H; Tanigawa M; Matsubayashi J; Hirano H; Shibahara J; Tada Y; Tsuzuki T; Okada Y; Sato Y; Ikeda K; Sukeda A; Honda Y; Mikami Y; Nagao T
    Histopathology; 2020 Feb; 76(3):411-422. PubMed ID: 31505033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.
    Lee YJ; Lee MY; Ruan A; Chen CK; Liu HP; Wang CJ; Chao WR; Han CP
    Oncotarget; 2016 Dec; 7(50):82097-82103. PubMed ID: 27888800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PIK3CA alterations in Middle Eastern ovarian cancers.
    Abubaker J; Bavi P; Al-Haqawi W; Jehan Z; Munkarah A; Uddin S; Al-Kuraya KS
    Mol Cancer; 2009 Jul; 8():51. PubMed ID: 19638206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
    Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
    J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach.
    Fisch AS; Laklouk I; Nakaguro M; Nosé V; Wirth LJ; Deschler DG; Faquin WC; Dias-Santagata D; Sadow PM
    Hum Pathol; 2021 Aug; 114():74-89. PubMed ID: 33991527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
    Hsieh MS; Lee YH; Chang YL
    Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Newly described salivary gland tumors.
    Skalova A; Michal M; Simpson RH
    Mod Pathol; 2017 Jan; 30(s1):S27-S43. PubMed ID: 28060365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Diagnostic Utility of RAS Q61R Mutation-specific Immunohistochemistry in Epithelial-Myoepithelial Carcinoma.
    Nakaguro M; Tanigawa M; Hirai H; Yamamoto Y; Urano M; Takahashi RH; Sukeda A; Okumura Y; Honda S; Tasaki K; Shimizu A; Tsukahara K; Tada Y; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
    Am J Surg Pathol; 2021 Jul; 45(7):885-894. PubMed ID: 33481388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.